47
Participants
Start Date
February 6, 2019
Primary Completion Date
March 18, 2023
Study Completion Date
April 6, 2023
IV Tedizolid Phosphate
A single dose, or twice daily dose for 3 days, of tedizolid phosphate administered IV.
Oral Suspension Tedizolid Phosphate
A single dose of tedizolid phosphate administered as an oral suspension.
Akershus Universitetssykehus HF ( Site 1604), Loerenskog
MHAT Sv. Ivan Rilski EOOD ( Site 2201), Kozloduy
"MHAT Dr. Stamen Iliev Montana ( Site 2215)", Montana
MHAT City Clinic Sv. Georgi EOOD ( Site 2202), Montana
Stavanger Universitetssykehus, Helse Stavanger ( Site 1601), Stavanger
Haukeland Universitetssjukehus ( Site 1602), Bergen
MHAT Dr. Tota Venkova-Pediatrics ( Site 2218), Gabrovo
Medical Center - 1- Sevlievo EOOD ( Site 2207), Sevlievo
UMHAT Dr. Georgi Stranski EAD ( Site 2211), Pleven
MHAT Rousse-Neonatology ( Site 2213), Rousse
Multiprofile Hospital for Active Treatment - Ruse ( Site 2204), Rousse
UMHAT Kanev AD ( Site 2209), Rousse
St. Olavs Hospital. ( Site 1600), Trondheim
UMHAT Deva Maria ( Site 2208), Burgas
MHAT Dr. Ival Seliminski ( Site 2212), Sliven
Ann & Robert H. Lurie Children's Hospital of Chicago ( Site 1022), Chicago
Saint Louis Children's Hospital ( Site 1020), St Louis
Our Lady of the Lake Regional Medical Center. ( Site 1004), Baton Rouge
Arkansas Children's Hospital ( Site 1012), Little Rock
Primary Children's Hospital ( Site 1000), Salt Lake City
Sharp Memorial Hospital ( Site 1021), San Diego
Children's Hospital of Orange County ( Site 1001), Orange
Fundacion Hospital Infantil Universitario de San Jose ( Site 1107), Bogotá
Fundacion Valle del Lili ( Site 1102), Santiago de Cali
Hospital San Vicente Fundacion ( Site 1103), Medellín
Clinica de la Costa S.A.S. ( Site 1106), Barranquilla
University Hospital Southampton NHS Foundation Trust ( Site 1700), Southampton
Alder Hey Childrens NHS Foundation Trust Hospital ( Site 1703), Liverpool
Royal Victoria Infirmary ( Site 1702), Newcastle
Oxford University Hospitals NHS Foundation Trust ( Site 1704), Oxford
Merck Sharp & Dohme LLC
INDUSTRY